FDA Accepts Ascendis Pharma’s sBLA for TransCon hGH, Targeting Adult GHD Ascendis Pharma has reached a significant milestone with the FDA's acceptance of its supplemental Biologics License Application (sBLA) for TransCon hGH, a treatment designed to address adult growth ho...

www.linkedin.com/pulse/fda-ac...

FDA Accepts Ascendis Pharma’s sBLA for TransCon hGH, Targeting Adult GHD

kstrategyand.com

#AscendisPharma #TransConhGH #GrowthHormoneDeficiency #GHD #FDAApproval #SKYTROFA #ClinicalTrials #PatientCare #Humanteconomy #Humantec #KStrategyand